ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Fmoc-N'-Boc-N'-isopropyl-L-lysine
C29H38N2O6
510.6 g/mol
Pharmaceutical Intermediate

N-Fmoc-N'-Boc-N'-isopropyl-L-lysine

CAS201003-48-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is an Fmoc-protected lysine derivative featuring orthogonal Boc and isopropyl protection on the side-chain nitrogen. It is primarily used as a building block in solid-phase peptide synthesis to introduce isopropyl-lysine residues.

building block for solid-phase peptide synthesispreparation of modified peptides containing N-isopropyl-lysine

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing N-Fmoc-N'-Boc-N'-isopropyl-L-lysine?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.82

N'-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N'-methyl-L-lysine

CAS951695-85-5

pharmaceutical intermediate

ReferenceSame Category

2-Amino-2'-chloro-5-nitro benzophenone

CAS2011-66-7

pharmaceutical intermediate

ReferenceSame Category

3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid tert-butyl ester

CAS201162-53-0

pharmaceutical intermediate

ReferenceSame Category

Methyl 4-acetamido-5-iodo-2-methoxybenzoate

CAS201214-53-1

pharmaceutical intermediate

ReferenceSame Category

(6-Amino-9H-purin-9-yl)acetic acid

CAS20128-29-4

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-ylamino]hexanoic acid

InChIKey

LUGFCMICCJNLBC-VWLOTQADSA-N

SMILES

CC(C)N(CCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C

Synonyms (13)
  • Fmoc-L-Lys(Boc, iPr)-OH
  • Fmoc-Lys(Boc)(isopropyl)-OH
  • Fmoc-Lys(ipr,Boc)-OH

Sourcing N-Fmoc-N'-Boc-N'-isopropyl-L-lysine?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→